Clinical Trials
18 trialsNCT04635384 2026-03-18
ACROBAT
CareDx
Active not recruiting
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT07145411 2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
NCT01688011 2025-07-03
Connect® Myeloid Disease Registry
Celgene
Terminated
NCT05735704 2025-03-26
SANGUINE
JaxBio Ltd
Unknown
NCT04036448 2025-03-11
RevlimidPMS
Celgene
Completed
NCT05218902 2023-05-31
DIM Vidaza
Bristol-Myers Squibb
Completed
NCT02921802 2022-06-14
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
Completed
NCT02921815 2022-06-14
A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment
Celgene
Completed
NCT04014764 2022-04-05
(ANSWer)
Notable Labs
Completed
NCT02085798 2020-01-27
Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)
Celgene
Completed
NCT02164071 2019-11-18
GAH
Celgene
Completed
NCT02891551 2019-07-24
OCEAN
Celgene
Completed
NCT02842229 2017-07-26
A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
Celgene
Completed
NCT01192945 2015-11-13
Piaza
iOMEDICO AG
Completed
NCT02188290 2015-10-06
Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
Kiadis Pharma
Completed
NCT01362985 2015-08-13
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor
Sanofi
Completed
NCT00596999 2012-04-10
HPDSC
Celgene
Unknown